Last reviewed · How we verify

NCT03906019

Indications of Erector Spinae Plane Block in Pediatric Patients

Completed Last updated 1 August 2019
What this trial tests

trial testing ESP Block in Postoperative Pain in 141 participants. Completed in 30 April 2019.

Timeline
9 April 2019
Primary endpoint
30 April 2019
30 April 2019

Quick facts

Lead sponsorKocaeli University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment141
Start date9 April 2019
Primary completion30 April 2019
Estimated completion30 April 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kocaeli University

Who can join

Adults 1 to 18, any sex, with Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients who were operated by Department of Pediatric Surgery between the 1 September 2017 and 28 February 2019 and who received erector spinae plane blocks as a part of postoperative analgesia management will be scanned.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Defining the Indications and Levels of Erector Spinae Plane Block in Pediatric Patients: A Retrospective Study of Our Current Experience.
    Aksu C, Gurkan Y. · · 2019 · cited 17× · PMID 31602352 · DOI 10.7759/cureus.5348

Verify or expand the search:

Other trials of ESP Block

Trials testing the same drug.

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other Kocaeli University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03906019.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing